Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Nelson

Showing results (161-170 of 179) with videos related to

Pageof 18
Sort By:
Frontiers in Ecology and the Environment|January 7, 2021
Panarchy: opportunities and challenges for ecosystem managementAhjond Garmestani, Dirac Twidwell, David G Angeler, et al.
Developmental Medicine and Child Neurology|July 27, 2010
Intracerebral large artery disease in Aicardi-Goutières syndrome implicates SAMHD1 in vascular homeostasisVenkateswaran Ramesh, Bruno Bernardi, Altin Stafa, et al.
Pathogenetics|February 26, 2010
A distinctive gene expression fingerprint in mentally retarded male patients reflects disease-causing defects in the histone demethylase KDM5CLars R Jensen, Heinz Bartenschlager, Sinitdhorn Rujirabanjerd, et al.
The Journal of Clinical Investigation|January 31, 2023
Cotargeting of BTK and MALT1 overcomes resistance to BTK inhibitors in mantle cell lymphomaVivian Changying Jiang, Yang Liu, Junwei Lian, et al.
Journal of Medicinal Chemistry|April 6, 2021
Structure-Based Design of Selective LONP1 Inhibitors for Probing <i>In Vitro</i> BiologyLaura J Kingsley, Xiaohui He, Matthew McNeill, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
Molecular Connectomics Reveals a Glucagon-Like Peptide 1 Sensitive Neural Circuit for SatietyAddison Nicole Webster, Jordan J Becker, Chia Li, et al.
Nature Genetics|May 27, 2003
Fraser syndrome and mouse blebbed phenotype caused by mutations in FRAS1/Fras1 encoding a putative extracellular matrix proteinLesley McGregor, Ville Makela, Susan M Darling, et al.
ACS Medicinal Chemistry Letters|December 17, 2021
Antitarget Selectivity and Tolerability of Novel Pyrrolo[2,3-<i>d</i>]pyrimidine RET InhibitorsCasey J N Mathison, Yang Yang, John Nelson, et al.
ACS Medicinal Chemistry Letters|April 16, 2020
Efficacy and Tolerability of Pyrazolo[1,5-<i>a</i>]pyrimidine RET Kinase Inhibitors for the Treatment of Lung AdenocarcinomaCasey J N Mathison, Donatella Chianelli, Paul V Rucker, et al.
ACS Medicinal Chemistry Letters|October 24, 2017
Identification of Potent and Selective RIPK2 Inhibitors for the Treatment of Inflammatory DiseasesXiaohui He, Sara Da Ros, John Nelson, et al.
Pageof 18

Showing results (161-170 of 179) with videos related to

Sort By:
Pageof 18
Frontiers in Ecology and the Environment|January 7, 2021
Panarchy: opportunities and challenges for ecosystem managementAhjond Garmestani, Dirac Twidwell, David G Angeler, et al.
Developmental Medicine and Child Neurology|July 27, 2010
Intracerebral large artery disease in Aicardi-Goutières syndrome implicates SAMHD1 in vascular homeostasisVenkateswaran Ramesh, Bruno Bernardi, Altin Stafa, et al.
Pathogenetics|February 26, 2010
A distinctive gene expression fingerprint in mentally retarded male patients reflects disease-causing defects in the histone demethylase KDM5CLars R Jensen, Heinz Bartenschlager, Sinitdhorn Rujirabanjerd, et al.
The Journal of Clinical Investigation|January 31, 2023
Cotargeting of BTK and MALT1 overcomes resistance to BTK inhibitors in mantle cell lymphomaVivian Changying Jiang, Yang Liu, Junwei Lian, et al.
Journal of Medicinal Chemistry|April 6, 2021
Structure-Based Design of Selective LONP1 Inhibitors for Probing <i>In Vitro</i> BiologyLaura J Kingsley, Xiaohui He, Matthew McNeill, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
Molecular Connectomics Reveals a Glucagon-Like Peptide 1 Sensitive Neural Circuit for SatietyAddison Nicole Webster, Jordan J Becker, Chia Li, et al.
Nature Genetics|May 27, 2003
Fraser syndrome and mouse blebbed phenotype caused by mutations in FRAS1/Fras1 encoding a putative extracellular matrix proteinLesley McGregor, Ville Makela, Susan M Darling, et al.
ACS Medicinal Chemistry Letters|December 17, 2021
Antitarget Selectivity and Tolerability of Novel Pyrrolo[2,3-<i>d</i>]pyrimidine RET InhibitorsCasey J N Mathison, Yang Yang, John Nelson, et al.
ACS Medicinal Chemistry Letters|April 16, 2020
Efficacy and Tolerability of Pyrazolo[1,5-<i>a</i>]pyrimidine RET Kinase Inhibitors for the Treatment of Lung AdenocarcinomaCasey J N Mathison, Donatella Chianelli, Paul V Rucker, et al.
ACS Medicinal Chemistry Letters|October 24, 2017
Identification of Potent and Selective RIPK2 Inhibitors for the Treatment of Inflammatory DiseasesXiaohui He, Sara Da Ros, John Nelson, et al.
Pageof 18